Feed MGNX
MG
MacroGenics, Inc.
MGNX · NASDAQ
$4.01 -6.53% (-$0.28)
1M -4.26%
Market Cap $273.3M
P/E Ratio -
Div. Yield -
ROE 147.81%
Bulios Fair Price
$153.92
3738.4% upside
Aktuální cena
$4.01
Podhodnoceno Férová hodnota Nadhodnoceno
Valuation
29 /100
Expensive P/B 12.89x
P/S 1.74x
P/FFO N/A
Growth
0 /100
Declining Book val. growth 26.85%
Rev. growth 0.12%
FCF growth N/A
Profitability
0 /100
Weak Op. margin 0.00%
Gross margin 0.00%
FCF margin 0.00%
Quality
6 /100
Poor ROA 0.00%
ROIC 0.00%
Asset turnover 0.72x
Debt
44 /100
Moderate Int. coverage -3.04x
Debt/Equity 1.72x
Net debt/EBITDA 0.45x
Stability
13 /100
Unstable EPS volatility 381.25%
Beta 1.18x
Profitable years 0
Zeptejte se StockBota na MGNX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Eric Risser
Employees
293
Headquarters
Rockville
Nadcházející události
13 SRP
Earnings
Upcoming earnings report